105 related articles for article (PubMed ID: 33250420)
1. N-Isopropylacrylamide-modified polyethylenimine-mediated miR-29a delivery to inhibit the proliferation and migration of lung cancer cells.
Xing J; Jia J; Cong X; Liu Z; Li Q
Colloids Surf B Biointerfaces; 2021 Feb; 198():111463. PubMed ID: 33250420
[TBL] [Abstract][Full Text] [Related]
2. N-Isopropylacrylamide-modified polyethylenimine-mediated p53 gene delivery to prevent the proliferation of cancer cells.
Zhang J; Wu D; Xing Z; Liang S; Han H; Shi H; Zhang Y; Yang Y; Li Q
Colloids Surf B Biointerfaces; 2015 May; 129():54-62. PubMed ID: 25829127
[TBL] [Abstract][Full Text] [Related]
3. Nucleobase-modified polyamidoamine-mediated miR-23b delivery to inhibit the proliferation and migration of lung cancer.
Han H; Yang J; Wang Y; Chen W; Chen J; Yang Y; Li Q
Biomater Sci; 2017 Oct; 5(11):2268-2275. PubMed ID: 28976503
[TBL] [Abstract][Full Text] [Related]
4. Lipoic Acid-Modified Oligoethyleneimine-Mediated miR-34a Delivery to Achieve the Anti-Tumor Efficacy.
Huang Y; Wang L; Chen Y; Han H; Li Q
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443415
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of cell proliferation and migration by chondroitin sulfate-g-polyethylenimine-mediated miR-34a delivery.
Liang S; Duan Y; Xing Z; Han H; Zhang A; Li L; Yang Y; Li Q
Colloids Surf B Biointerfaces; 2015 Dec; 136():577-84. PubMed ID: 26454548
[TBL] [Abstract][Full Text] [Related]
6. Delivery of DNAzyme targeting aurora kinase A to inhibit the proliferation and migration of human prostate cancer.
Xing Z; Gao S; Duan Y; Han H; Li L; Yang Y; Li Q
Int J Nanomedicine; 2015; 10():5715-27. PubMed ID: 26425080
[TBL] [Abstract][Full Text] [Related]
7. N-Isopropylacrylamide Modified Polyethylenimines as Effective siRNA Carriers for Cancer Therapy.
Chen J; Lin L; Guo Z; Xu C; Li Y; Tian H; Tang Z; He C; Chen X
J Nanosci Nanotechnol; 2016 Jun; 16(6):5464-9. PubMed ID: 27427585
[TBL] [Abstract][Full Text] [Related]
8. Phenylboronic Acid-Modified Polyamidoamine Mediated the Transfection of Polo-Like Kinase-1 siRNA to Achieve an Anti-Tumor Efficacy.
Gong G; Tang X; Zhang J; Liang X; Yang J; Li Q
Int J Nanomedicine; 2021; 16():8037-8048. PubMed ID: 34934312
[TBL] [Abstract][Full Text] [Related]
9. Study on molecular mechanism of MiRNA-29a in promoting proliferation and invasion of non-small-cell lung cancer by inhibiting MTSS1.
Liu M; Zeng X; Lu YX; Mo YJ; Liao TH; Gan C; Lu XQ
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5531-5538. PubMed ID: 30229825
[TBL] [Abstract][Full Text] [Related]
10. MiR-29a inhibits cell proliferation and migration by targeting the CDC42/PAK1 signaling pathway in cervical cancer.
Chen R; Zhang L
Anticancer Drugs; 2019 Jul; 30(6):579-587. PubMed ID: 30724771
[TBL] [Abstract][Full Text] [Related]
11. MiRNA-29a regulates the expression of numerous proteins and reduces the invasiveness and proliferation of human carcinoma cell lines.
Muniyappa MK; Dowling P; Henry M; Meleady P; Doolan P; Gammell P; Clynes M; Barron N
Eur J Cancer; 2009 Nov; 45(17):3104-18. PubMed ID: 19818597
[TBL] [Abstract][Full Text] [Related]
12. Reduced miR-29a-3p expression is linked to the cell proliferation and cell migration in gastric cancer.
Zhao Z; Wang L; Song W; Cui H; Chen G; Qiao F; Hu J; Zhou R; Fan H
World J Surg Oncol; 2015 Mar; 13():101. PubMed ID: 25889078
[TBL] [Abstract][Full Text] [Related]
13. MiR-29a-5p inhibits proliferation and invasion and induces apoptosis in endometrial carcinoma via targeting TPX2.
Jiang T; Sui D; You D; Yao S; Zhang L; Wang Y; Zhao J; Zhang Y
Cell Cycle; 2018; 17(10):1268-1278. PubMed ID: 29888640
[TBL] [Abstract][Full Text] [Related]
14. Effect of oligonucleotide MT01 delivered by N-isopropylacrylamide modified polyethyleneimine for bone regeneration.
Zhang Q; Qu X; Liang C; Li H; Du S; Wang C; Xie Y; Zheng Y; Wang L
Front Bioeng Biotechnol; 2023; 11():1204571. PubMed ID: 37404683
[No Abstract] [Full Text] [Related]
15. Selenium-mediated gga-miR-29a-3p regulates LMH cell proliferation, invasion, and migration by targeting COL4A2.
Hu X; Tan S; Yin H; Khoso PA; Xu Z; Li S
Metallomics; 2020 Mar; 12(3):449-459. PubMed ID: 32039426
[TBL] [Abstract][Full Text] [Related]
16. LncRNA BLACAT1 Promotes Proliferation, Migration and Invasion of Prostate Cancer Cells via Regulating miR-29a-3p/DVL3 Axis.
Liao B; Chen S; Li Y; Yang Z; Yang Y; Deng X; Ke S
Technol Cancer Res Treat; 2021; 20():1533033820972342. PubMed ID: 33641528
[TBL] [Abstract][Full Text] [Related]
17. Phenylboronic acid-functionalized polyamidoamine-mediated miR-34a delivery for the treatment of gastric cancer.
Song Z; Liang X; Wang Y; Han H; Yang J; Fang X; Li Q
Biomater Sci; 2019 Mar; 7(4):1632-1642. PubMed ID: 30720809
[TBL] [Abstract][Full Text] [Related]
18. lncRNA-H19/miR-29a axis affected the viability and apoptosis of keloid fibroblasts through acting upon COL1A1 signaling.
Wang Z; Feng C; Song K; Qi Z; Huang W; Wang Y
J Cell Biochem; 2020 Nov; 121(11):4364-4376. PubMed ID: 31930556
[TBL] [Abstract][Full Text] [Related]
19. Delivery of miR-29a improves the permeability of cisplatin by downregulating collagen I expression.
Qin Z; Ma J; Chu X; Guo T; Feng P; Wang M
Biochem Biophys Res Commun; 2024 May; 710():149884. PubMed ID: 38598901
[TBL] [Abstract][Full Text] [Related]
20. miRNA-29a reverses P-glycoprotein-mediated drug resistance and inhibits proliferation via up-regulation of PTEN in colon cancer cells.
Shi X; Valizadeh A; Mir SM; Asemi Z; Karimian A; Majidina M; Safa A; Yosefi B
Eur J Pharmacol; 2020 Aug; 880():173138. PubMed ID: 32416187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
